参考文献/References:
[1] Ma RCW.Epidemiology of diabetes and diabetic complications in China[J].Diabetologia,2018,61(6):1249-1260.DOI:10.1007/s00125-018-4557-7.
[2] Ferrara D,Montecucco F,Dallegri F,et al.Impact of different ectopic fat depots on cardiovascular and metabolic diseases[J].J Cell Physiol,2019,234(12):21630-21641.DOI:10.1002/jcp.28821.
[3] Smits MM,van Geenen EJ.The clinical significance of pancreatic steatosis[J].Nat Rev Gastroenterol Hepatol,2011,8(3):169-177.DOI:10.1038/nrgastro.2011.4.
[4] Walters MN.Adipose atrophy of the exocrine pancreas[J].J Pathol Bacteriol,1966,92(2):547-557.DOI:10.1002/path.1700920232.
[5] Patel S,Bellon EM,Haaga J,et al.Fat replacement of the exocrine pancreas[J].AJR Am J Roentgenol,1980,135(4):843-845.DOI:10.2214/ajr.135.4.843.
[6] Raeder H,Haldorsen IS,Ersland L,et al.Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase[J].Diabetes,2007,56(2):444-449.DOI:10.2337/db06-0859.
[7] Tushuizen ME,Bunck MC,Pouwels PJ,et al.Pancreatic fat content and beta-cell function in men with and without type 2 diabetes[J].Diabetes Care,2007,30(11):2916-2921. DOI:10.2337/dc07-0326.
[8] Mathur A,Marine M,Lu D,et al.Nonalcoholic fatty pancreas disease[J].HPB(Oxford),2007,9(4):312-318.DOI:10.1080/13651820701504157.
[9] Pitt HA.Hepato-pancreato-biliary fat:the good, the bad and the ugly[J].HPB(Oxford),2007,9(2):92-97.DOI:10.1080/13651820701286177.
[10] Pinnick KE,Collins SC,Londos C,et al.Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition[J].Obesity(Silver Spring),2008,16(3):522-530.DOI:0.1038/oby.2007.110.
[11] Altinel D,Basturk O,Sarmiento JM,et al.Lipomatous pseudohypertrophy of the pancreas: a clinicopathologically distinct entity[J].Pancreas,2010,39(3):392-397.DOI:10.1097/MPA.0b013e3181bd2923.
[12] Zhou J,Li ML,Zhang DD,et al.The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population[J].Pancreatology,2016,16(4):578-583.DOI:10.1016/j.pan.2016.03.008.
[13] Pham YH,Bingham BA,Bell CS,et al.Prevalence of pancreatic steatosis at a pediatric tertiary care center[J].South Med J,2016,109(3):196-198.DOI:10.14423/SMJ.0000000000000432.
[14] Gerst F,Wagner R,Kaiser G,et al.Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion[J].Diabetologia,2017,60(11):2240-2251.DOI:10.1007/s00125-017-4385-1.
[15] Mortelé KJ,Rocha TC,Streeter JL,et al. Multimodality imaging of pancreatic and biliary congenital anomalies[J].Radiographics,2006,26(3):715-731.DOI:10.1148/rg.263055164.
[16] Di Serafino M,Vitale V,Severino R,et al.Pediatric ultrasonography of the pancreas: normal and abnormal findings[J].J Ultrasound,2019,22(3):261-272.DOI:10.1007/s40477-018-0348-8.
[17] Miyake H,Sakagami J,Yasuda H,et al.Association of fatty pancreas with pancreatic endocrine and exocrine function[J].PLoS One,2018,13(12):e0209448.DOI:10.1371/journal.pone.0209448.
[18] Saisho Y.Pancreas volume and fat deposition in diabetes and normal physiology:consideration of the interplay between endocrine and exocrine pancreas[J].Rev Diabet Stud,2016,13(2-3):132-147.DOI:10.1900/RDS.2016.13.132.
[19] Bray TJ,Chouhan MD,Punwani S,et al.Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology[J].Br J Radiol,2018,91(1089):20170344.DOI:10.1259/bjr.20170344.
[20] Yuan F,Song B,Huang Z,et al. Quantification of pancreatic fat with dual-echo imaging at 3.0-T MR in clinical application: how do the corrections for T1 and T2* relaxation effect work and simplified correction strategy[J].Acta Radiol,2018,59(9):1021-1028.DOI:10.1177/0284185117745908.
[21] Lee JJ,Wang PW,Yang IH,et al.High-fat diet induces toll-like receptor 4-dependent macrophage/microglial cell activation and retinal impairment[J].Invest Ophthalmol Vis Sci,2015,56(5):3041-3050.DOI:10.1167/iovs.15-16504.
[22] Xu X,Liang T,Lin X,et al.Effect of the total extract of averrhoacarambola(Oxalidaceae)root on the expression levels of TLR4 and NF-κB in streptozotocin-induced diabetic mice[J].Cell Physiol Biochem,2015,36(6):2307-2316.DOI:10.1159/000430194.
[23] Larsen CM,Faulenbach M,Vaag A,et al.Interleukin-1-receptor antagonist in type 2 diabetes mellitus[J].N Engl J Med,2007,356(15):1517-1526.DOI:10.1056/NEJMoa065213.
[24] Park YJ,Woo M.Pancreatic β cells:gatekeepers of type 2 diabetes[J].J Cell Biol,2019,218(4):1094-1095.DOI:10.1083/jcb.201810097.
[25] Heni M,Machann J,Staiger H,et al.Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fastingglucose and/or impaired glucose tolerance: a nuclear magnetic resonance study[J].Diabetes Metab Res Rev,2010,26(3):200-205.DOI:10.1002/dmrr.1073.
[26] Dong Z,Luo Y,Cai H,et al.Noninvasive fat quantification of the liver and pancreas may provide potential biomarkers of impaired glucose tolerance and type 2 diabetes[J].Medicine(Baltimore),2016,95(23):e3858.DOI:10.1097/MD.0000000000003858.
[27] Ou HY,Wang CY,Yang YC,et al.The association between nonalcoholic fatty pancreas disease and diabetes[J].PLoS One,2013,8(5):e62561.DOI:10.1371/journal.pone.0062561.
[28] Nadarajah C,Fananapazir G,Cui E,et al. Association of pancreatic fat content with type II diabetes mellitus[J].Clin Radiol,2020,75(1):51-56.DOI:10.1016/j.crad.2019.05.027.
[29] Muollo V,Rossi AP,Milanese C,et al.The effects of exercise and diet program in overweight people-Nordic walking versus walking[J].Clin Interv Aging,2019,14:1555-1565.DOI:10.2147/CIA.S217570.
[30] Jiang Y,Spurny M,Schübel R,et al.Changes in pancreatic fat content following diet-induced weight loss[J].Nutrients,2019,11(4):pii:E912.DOI:10.3390/nu11040912.
[31] Sudhakara G,Mallaiah P,Rajendran R,et al.Caralluma fimbriata and metformin protection of rat pancreas from high fat diet induced oxidativestress[J].Biotech Histochem,2018,93(3):177-187.DOI:10.1080/10520295.2017.1406615.
相似文献/References:
[1]曹琳,杨昱,刘超.减重手术对多囊卵巢综合征的治疗作用[J].国际内分泌代谢杂志,2014,(06):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
Cao Lin,Yang Yu,Liu Chao..Therapeutic effects of bariatric surgery on polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(04):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
[2]张莎莎,孟杰杰,沈桂芬,等.肌肉生长抑制素前肽基因干预对高脂饮食诱导的肥胖小鼠脂代谢的影响[J].国际内分泌代谢杂志,2014,(06):361.[doi:10.3760/cma.j.issn.1673-4157.2014.06.001]
Zhang Shasha*,Meng Jiejie,Shen Guifen,et al.Effects of myostatin propeptide gene intervention on dyslipidemia in high fat diet-induced obese mice[J].International Journal of Endocrinology and Metabolism,2014,(04):361.[doi:10.3760/cma.j.issn.1673-4157.2014.06.001]
[3]郝圆圆,张婷婷,袁红网,等.增食欲素干预单纯性肥胖的作用及机制[J].国际内分泌代谢杂志,2014,(05):324.[doi:10.3760/cma.j.issn.1673-4157.2014.05.010]
Hao Yuanyuan,Zhang Tingting,Yuan Hongwang,et al.Effects of orexin on obesity and its mechanism[J].International Journal of Endocrinology and Metabolism,2014,(04):324.[doi:10.3760/cma.j.issn.1673-4157.2014.05.010]
[4]史俊奇 邹朝春.MicroRNA与肥胖[J].国际内分泌代谢杂志,2015,(05):344.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.014]
Shi Junqi,Zou Chaochun..MicroRNA and obesity[J].International Journal of Endocrinology and Metabolism,2015,(04):344.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.014]
[5]张如意 张桦 王娇 孙嘉 陈容平 杨锐 冉建民 陈宏.超重或肥胖2型糖尿病患者糖尿病足的
患病率及相关危险因素分析[J].国际内分泌代谢杂志,2015,(06):365.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.002]
Zhang Ruyi*,Zhang Hua,Wang Jiao,et al.Prevalence and risk factors for diabetic foot in overweight or obese type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(04):365.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.002]
[6]刘剑 吴明昊 高宇.高脂饮食影响消化系统致肥胖的机制[J].国际内分泌代谢杂志,2015,(06):402.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.011]
Liu Jian*,Wu Minghao,Gao Yu..The mechanism of obesity caused by disturbance of high fat diets on gastrointestinal system[J].International Journal of Endocrinology and Metabolism,2015,(04):402.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.011]
[7]张琳,费雯婕,宋光耀.网膜素与代谢综合征[J].国际内分泌代谢杂志,2016,36(01):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]
Zhang Lin*,Fei Wenjie,Song Guangyao..Omentin and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2016,36(04):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]
[8]谢绍锋,黄莉吉,王昆,等.南京市城区40岁以上人群超重、肥胖流行
特点调查分析[J].国际内分泌代谢杂志,2016,36(03):145.[doi:10.3760/cma.j.issn.1673-4157.2016.03.01]
Xie Shaofeng*,Huang Liji,Wang Kun,et al.Epidemiological investigation of overweight and obesity in population aged 40 years or older in Nanjing City[J].International Journal of Endocrinology and Metabolism,2016,36(04):145.[doi:10.3760/cma.j.issn.1673-4157.2016.03.01]
[9]杨曦,刘玉洁,马慧娟.C1q/肿瘤坏死因子相关蛋白12与糖代谢[J].国际内分泌代谢杂志,2016,36(03):195.[doi:10.3760/cma.j.issn.1673-4157.2016.03.13]
Yang Xi*,Liu Yujie,Ma Huijuan..C1q/tumor necrosis factor-related protein 12 and glucose metabolism[J].International Journal of Endocrinology and Metabolism,2016,36(04):195.[doi:10.3760/cma.j.issn.1673-4157.2016.03.13]
[10]赵一璟,陈国芳,刘超.代餐饮食在肥胖和超重患者中的应用[J].国际内分泌代谢杂志,2016,36(05):323.[doi:10.3760/cma.j.issn.1673-4157.2016.05.10]
Zhao Yijing*,Chen Guofang,Liu Chao.Application of meal replacement in obese and overweight patients[J].International Journal of Endocrinology and Metabolism,2016,36(04):323.[doi:10.3760/cma.j.issn.1673-4157.2016.05.10]